MERAVIGLIA, Serena
 Distribuzione geografica
Continente #
NA - Nord America 9.820
EU - Europa 5.645
AS - Asia 4.727
SA - Sud America 741
AF - Africa 140
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.102
Nazione #
US - Stati Uniti d'America 9.578
SG - Singapore 1.678
RU - Federazione Russa 1.457
IT - Italia 1.413
CN - Cina 1.187
FI - Finlandia 586
BR - Brasile 571
HK - Hong Kong 504
DE - Germania 480
UA - Ucraina 414
VN - Vietnam 404
PL - Polonia 284
GB - Regno Unito 254
FR - Francia 205
BD - Bangladesh 186
JP - Giappone 178
IE - Irlanda 153
CA - Canada 136
IN - India 136
SE - Svezia 110
KR - Corea 94
NL - Olanda 68
AR - Argentina 58
AT - Austria 48
TR - Turchia 47
MX - Messico 46
IQ - Iraq 45
CI - Costa d'Avorio 42
IR - Iran 37
ES - Italia 36
BE - Belgio 33
PK - Pakistan 33
UZ - Uzbekistan 33
RO - Romania 30
ZA - Sudafrica 28
CL - Cile 22
VE - Venezuela 22
AU - Australia 20
SA - Arabia Saudita 20
CR - Costa Rica 18
MA - Marocco 18
CO - Colombia 17
PH - Filippine 17
ID - Indonesia 16
NP - Nepal 15
EC - Ecuador 14
JO - Giordania 13
KE - Kenya 13
MY - Malesia 13
PY - Paraguay 13
JM - Giamaica 12
RS - Serbia 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
BO - Bolivia 9
DZ - Algeria 9
EG - Egitto 7
KZ - Kazakistan 7
OM - Oman 7
TN - Tunisia 7
UY - Uruguay 7
AL - Albania 6
AZ - Azerbaigian 6
BY - Bielorussia 6
GR - Grecia 6
NI - Nicaragua 6
PE - Perù 6
TH - Thailandia 6
KG - Kirghizistan 5
PA - Panama 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EU - Europa 4
IL - Israele 4
LB - Libano 4
LT - Lituania 4
NG - Nigeria 4
PT - Portogallo 4
SN - Senegal 4
SV - El Salvador 4
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
MK - Macedonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
AM - Armenia 2
ET - Etiopia 2
GD - Grenada 2
GY - Guiana 2
KH - Cambogia 2
MD - Moldavia 2
MM - Myanmar 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
Totale 21.083
Città #
Ashburn 1.198
Singapore 1.148
Fairfield 810
Chandler 602
San Jose 601
Hong Kong 483
Woodbridge 478
Houston 438
Ann Arbor 408
Palermo 366
Wilmington 323
Seattle 321
Moscow 265
Zgierz 237
Jacksonville 226
Cambridge 222
Des Moines 212
Los Angeles 194
Beijing 193
Council Bluffs 172
Tokyo 167
New York 165
Santa Clara 158
Dublin 153
Dallas 149
Medford 145
Boardman 136
The Dalles 134
Ho Chi Minh City 123
Milan 116
Lauterbourg 109
Hanoi 108
Frankfurt am Main 102
Hefei 96
Princeton 91
Altamura 87
Helsinki 87
Nanjing 83
Chicago 71
Buffalo 69
Rome 67
Lawrence 66
San Diego 58
Tulsa 58
Dearborn 56
London 49
Ludwigshafen am Rhein 44
Orem 43
São Paulo 43
Abidjan 41
Munich 41
Warsaw 41
Montreal 40
Amsterdam 37
Phoenix 37
Brussels 33
Nanchang 32
Tianjin 32
Denver 31
Guangzhou 30
Jinan 30
Shenyang 30
Seoul 29
Venice 29
Atlanta 28
Piscataway 27
Changsha 25
Nuremberg 25
Stockholm 25
Bremen 24
Brooklyn 24
Jiaxing 24
Tashkent 24
Columbus 23
Hebei 23
Da Nang 22
Johannesburg 22
Kumar 22
Vienna 22
Ottawa 21
Salt Lake City 21
Turku 21
Naples 20
Poplar 20
Tehran 20
Shanghai 19
Toronto 19
Washington 19
Paris 18
Rio de Janeiro 18
Turin 18
Baghdad 17
Lappeenranta 17
Chennai 16
Falls Church 16
Seongnam 16
Boston 15
Catania 15
Mumbai 15
San José 15
Totale 12.979
Nome #
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition 347
γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion 340
LEMON-DERIVED EXTRACELLULAR VESICLES EXERT ANTI-INFLAMMATORY EFFECTS BY INHIBITING THE ERK/NF-KB PATHWAY 311
Characterization of human infiltrating and circulating gamma-delta t cells in prostate cancer 308
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage 305
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 302
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 291
Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection 286
Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome 259
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis 246
Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer 241
Immunotherapy targeting colon cancer stem cells 239
Aminobisphosphonate-activated gammadelta T cells in immunotherapy of cancer: doubts no more. 237
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes 236
Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response 235
An overview of the role of T cells in controlling tuberculosis infection in a pediatric population 234
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 234
Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status 232
Decreased serum granulysin levels in childhood tuberculosis whinch reverse after therapy 230
Differentiation, phenotype, and function of interleukin-17-producing human V{gamma}9V{delta}2 T cells 222
Differentiation of human CD8+ T cells in BCG vaccinated and tuberculous patients. 220
Anti-inflammatory properties of lemon-derived extracellular vesicles are achieved through the inhibition of ERK/NF-κB signalling pathways 218
Γ δ T Cell-Based Immunotherapy in Melanoma: State of the Art 218
V{gamma}9V{delta}2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. 214
Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. 213
Current Advances in γδ T Cell-Based Tumor Immunotherapy 213
Immunomodulation in vascularized composite allotransplantation: What is the role for adipose-derived stem cells? 211
Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. 210
A SUBSET OF VGAMMA9 VDELTA2 T CELLS HELP B CELLS FOR ANTIBODY PRODUCTION. 210
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. 210
γδ T cells as a potential tool in colon cancer immunotherapy 207
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 207
Aminobisphosphonates as New Weapons for gammaDelta T Cell-Based Immunotherapy of Cancer 206
A risk score derived from the analysis of a cluster of 27 serum inflammatory cytokines to predict long term outcome in patients with acute myocardial infarction: A pilot study 205
Vg9Vd2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies 204
Cell Mediated Immune System Hyperactivation and Complications in Surgery. Is There a Correlation? 202
Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes 202
Immune Cells, Cytokines, and Gut Microbiota Landscape Along Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Evolution 200
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells 199
Metabolic changes in tumor microenvironment: How could they affect γδ t cells functions? 197
Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome 196
Tuning inflammation in tuberculosis: the role of decoy receptors 196
Integrated Multi-Omic Profiling of Immune, Soluble, and Microbial Signatures Identifies Predictors of Multiple Myeloma Evolution 195
CXCR5 identifies a subset of Vgamma9 Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production. 192
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 191
Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy. 191
γδ cells and tumor microenvironment: A helpful or a dangerous liason? 191
Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity. 188
Cross-talk between gamma delta T cells and dendritic cells in anti-mycobacterial immune response 188
Activation of human V gamma9 V delta 2 T cells by plasmacytoid dendritic cells 187
New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response 186
T-Cell Subsets (TCM, TEM, TEMRA) and Poly-Functional Immune Response in Patients with Human Immunodeficiency Virus (HIV) Infection and Different T-CD4 Cell Response 184
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again 182
Heterogeneity and prognostic influence of tumor- infiltrating γδ T lymphocytes in colon cancer patients 182
Mapping Cell-Cell Communication Dynamics Across the Spectrum of Multiple Myeloma Evolution Using Single-Cell Transcriptomics 181
Partial and Ineffective Activation of V{gamma}9V{delta}2 T Cells by Mycobacterium tuberculosis-Infected Dendritic Cells 181
γδ cell-based immunotherapy for cancer. 181
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer 180
A novel ELISA system for detecting serum granulysin in tuberculosis patients 178
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity 178
HUMAN MEMORY VGAMMA9 VDELTA2 T CELLS REQUIRE HOMEOSTATIC CYTOKINES FOR PROLIFERATION AND DIFFERENTIATION. 176
In vitro effects of aminobisphosphonates on Vgamma9Vdelta2 T cell activation and differentiation. 175
gd T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis 173
Advances in immunotherapy of castration-resistant prostate cancer: Bisphosphonates, phosphoantigens and more. 172
Memory and effector CD8 T cell subset in human tuberculosis. 170
Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis 170
Effects of the static magnetic field generated by a 1,5 T MRI unit on TNF-a release and TNF-receptor II expression of human monocyes 170
An analysis of the immunomodulatory properties of human spheroids from adipose-derived stem cells 169
EFFECTS OF THE STATIC MAGNETIC FIELD GENERATED BY A 1.5 T MRI UNIT ON TNF ALFA RELEASE AND TNF RECEPTOR II EXPRESSION OF HUMAN MONOCYTES. 169
Characterisation of γδ T cells infiltrating colorectal cancer 169
Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets. 167
Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment 166
Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells 165
Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes 164
Cross-talk between human myeloid dendritic cells and VG9VD2 T cells during M. tuberculosis infection. 163
Memory and effector CD8 T cell subsets in human tuberculosis. 162
Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy 160
The expanding universe of gamma delta T lymphocytes: subsets, generation and function 160
Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients 157
Multi-Omic Profiling of NK Cell Dysfunction and Tumor Immune Escape in Multiple Myeloma Evolution 152
Sicilian semi- and supercentenarians: identification of age-related T-cell immunophenotype to define longevity trait 152
gammadelta T Cell Modulation in Anticancer Treatment 150
Autologous conditioned serum for chronic pain in patients with osteoarthritis: A feasibility observational study 149
Clonal expansion shapes the human Vδ1T cell receptor repertoire. 149
Differentiation of human Vgamma9 Vdelta 2 T cell subsets by antigen or homeostatic cytokines 148
Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients 145
Exosomes released by chronic myelogenous leukemia cells modulate gamma-delta T cell activities 144
ThO to Th1 switch of CD4T cell clones specific from the 16-kDa antigen of Mycobacterium tuberculosis after successfull therapy: lack of involvement of epitope repertoire and HLA-DR 140
Unveiling Novel Therapeutic Targets for CAR Therapy in Multiple Myeloma through Single-Cell RNA Sequencing 139
Frequency, phenotype and function of Mycobacterium tuberculosis-specific CD8 T cells in patients with active tuberculosis and in individuals with latent infection 136
Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma 135
Correlation between tissue-harvesting method and donor-site with the yield of spheroids from adipose-derived stem cells 133
Deciphering human γδ T cell response in cancer: Lessons from tumor-infiltrating γδ T cells 132
Homing and memory patterns of human gamma delta T cells in physiopathological situations 131
High TIM-3 Expression May Contribute to the Functional Impairment of Bone Marrow and Circulating Gamma Delta T Lymphocytes during the Progression of Multiple Myeloma 131
Re: Correlation between tissue-harvesting method and donor-site with the yield of spheroids from adipose-derived stem cells 131
Frequency and subset distribution of human CD8 T cells specific for mycobacterial peptides in healthy contact individuals. 130
Il Complesso Maggiore di Istocompatibilità ed il Rigetto dei Trapianti 126
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis 125
Deciphering the Interplay of Immune Alterations and Microbiome Changes Along Multiple Myeloma Evolution From Premalignant Conditions 124
Totale 19.308
Categoria #
all - tutte 72.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.186 40 259 16 47 63 51 66 73 145 154 80 192
2022/20231.873 156 297 21 205 205 265 213 145 209 12 95 50
2023/20241.053 33 126 90 86 50 202 114 92 31 34 24 171
2024/20252.536 66 173 254 195 84 76 223 178 163 301 336 487
2025/20269.193 800 209 477 785 927 1.345 1.180 891 650 1.019 426 484
2026/2027248 248 0 0 0 0 0 0 0 0 0 0 0
Totale 21.744